The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 02, 2021

Filed:

Sep. 16, 2019
Applicant:

Astex Pharmaceuticals, Inc., Pleasanton, CA (US);

Inventors:

Pasit Phiasivongsa, Brentwood, CA (US);

Sanjeev Redkar, San Ramon, CA (US);

Assignee:

ASTEX PHARMACEUTICALS, INC., Pleasanton, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); C07H 19/20 (2006.01); C07H 21/00 (2006.01); A61K 31/7084 (2006.01); C12N 15/11 (2006.01); A61K 31/282 (2006.01); A61K 31/337 (2006.01); A61K 31/4406 (2006.01); A61K 33/24 (2019.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7084 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/4406 (2013.01); A61K 33/24 (2013.01); A61K 45/06 (2013.01); C07H 19/20 (2013.01); C07H 21/00 (2013.01); C12N 15/111 (2013.01); C12N 2310/11 (2013.01); C12N 2310/317 (2013.01); C12N 2310/334 (2013.01); C12N 2310/336 (2013.01); C12N 2320/30 (2013.01); C12N 2330/30 (2013.01);
Abstract

Oligonucleotide analogues are provided that incorporate 5-aza-cytosine in the oligonucleotide sequence, e.g., in the form of 5-aza-2'-deoxycytidine (decitabine) or 5-aza-cytidine. In particular, oligonucleotide analogues rich in decitabine-deoxyguanosine islets (DpG and GpD) are provided to target the CpG islets in the human genome, especially in the promoter regions of genes susceptible to aberrant hypermethylation. Such analogues can be used for modulation of DNA methylation, such as effective inhibition of methylation of cytosine at the C-5 position. Methods for synthesizing these oligonucleotide analogues and for modulating nucleic acid methylation are provided. Also provided are phosphoramidite building blocks for synthesizing the oligonucleotide analogues, methods for synthesizing, formulating and administering these compounds or compositions to treat conditions, such as cancer and hematological disorders.


Find Patent Forward Citations

Loading…